Cholinergic interneuron control of GABAergic circuits targeting spiny projection neurons is disrupted in parkinsonian models
Authors:
- Marziyeh BelalMBMarziyeh Belal
- Tamara Perez-RoselloTPTamara Perez-Rosello
- Elif B. GuvenEGElif B. Guven
- Samet KocaturkSKSamet Kocaturk
- Zhong XieZXZhong Xie
- Ema IlijicEIEma Ilijic
- Tatiana TkatchTTTatiana Tkatch
- William DauerWDWilliam Dauer
- Maxime AssousMAMaxime Assous
- James M. TepperJTJames M. Tepper
- Vernon R. J. ClarkeVCVernon R. J. Clarke
Preprint
Abstract
Parkinson's disease (PD) is known to alter the intrinsic properties of striatal cholinergic interneurons (ChIs). However, how PD shapes ChI control of intrastriatal GABAergic circuits regulating principal spiny projection neurons (SPNs) is unknown. To fill this gap, striatal circuits in healthy and parkinsonian mice were interrogated. In ex vivo brain slices from healthy mice, optogenetic stimulation of ChIs evoked GABA A receptor currents in both indirect and direct pathway SPNs that were attributable to nicotinic acetylcholine receptor (nAChR)-mediated activation of GABAergic interneurons (GIs). Simulations suggested that this circuit exerts a state-dependent control of SPN dendritic integration that was modulated by concomitant muscarinic receptor signaling. Surprisingly, in mouse models of prodromal and parkinsonian states, the ability of ChIs to engage this intrastriatal circuitry was disrupted because interneurons down-regulated nicotinic AChRs. Taken together, these studies suggest that impaired ChI control of GABAergic interneurons contributes to behavioral deficits in both prodromal and clinical PD states.Keywords
Funding Information
- Aligning Science Across Parkinsons through the Michael J. Fox Foundation for Parkinsons Research (MJFF) (ASAP020551)
- Freedom Together Foundation (GR-2021-2960)
- National Institute of Neurological Disorders and Stroke (R37 NS034696)
This publication has 58 references indexed in Scilit:
- Leveraging animal models to understand non-motor symptoms of Parkinson's diseaseNeurobiology of Disease, 2025
- Layer 1 NDNF interneurons are specialized top-down master regulators of cortical circuitsCell Reports, 2024
- Distributed dopaminergic signaling in the basal ganglia and its relationship to motor disability in Parkinson's diseaseCurrent Opinion in Neurobiology, 2023
- Cholinergic control of striatal GABAergic microcircuitsCell Reports, 2022
- Striatal synaptic adaptations in Parkinson's diseaseNeurobiology of Disease, 2022
- Optogenetic Editing Reveals the Hierarchical Organization of Learned Action SequencesCell, 2018
- Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in Experimental ParkinsonismCell Reports, 2016
- Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspectiveMovement Disorders, 2014
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967